Your shopping cart is currently empty

Nifedipine-13C8 is a deuterium-labeled form of Nifedipine. Nifedipine (BAY-a-1040) acts as an effective calcium channel blocker, frequently utilized in studies related to myocardial dysfunction.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Nifedipine-13C8 is a deuterium-labeled form of Nifedipine. Nifedipine (BAY-a-1040) acts as an effective calcium channel blocker, frequently utilized in studies related to myocardial dysfunction. |
| In vivo | At the conclusion of the fourth week, there is a significant increase (P < 0.05) in the BL dimensions (BLi and BLk), MD dimensions (MDk), and vertical dimensions (VHi and VHk) in rats treated with Nifedipine (BAY-a-1040) (50 mg/kg) and CsA. |
| Molecular Weight | 354.28 |
| Formula | C17H18N2O6 |
| Cas No. | 1173023-46-5 |
| Smiles | CO[13C]([13C]1=[13C]([13CH3])N[13C]([13CH3])=[13C]([13C](OC)=O)C1C2=C(C=CC=C2)[N+]([O-])=O)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.